OUTCOMES AND COSTS ASSOCIATED WITH INITIATING MAINTENANCE TREATMENT WITH FLUTICASONE PROPIONATE 250MCG/SALMETEROL XINAFOATE 50MCG COMBINATION (FSC) VERSUS ANTICHOLINERGICS INCLUDING TIOTROPIUM (TIO) IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD):